The European Union's pharmaceutical sector is in a constant state of evolution. With exacting regulations, expanding patient expectations, and the swift pace of innovation, navigating this challenging landscape requires a strategic approach. Pharmaceutical companies must evolve to this challenges by adopting advanced technologies, working with key